Contact Us

Patient Information:

Regarding Patient Participation in Ongoing Clinical Trials

Contact:

(713) 341-6475

Investor Relations:

To Contact Bellicum Pharmaceuticals

Contact:

(713) 341-6472

Send or Request Information from Bellicum:

Visit Contact Us Page

Bellicum Pharmaceuticals
PDF Print E-mail

Bellicum Pharmaceuticals, Inc. is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.